Remove categories india
article thumbnail

Sanofi signs distribution pact with Cipla for CNS portfolio in India

Express Pharma

Sanofi India and Cipla announced an exclusive partnership for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India. The post Sanofi signs distribution pact with Cipla for CNS portfolio in India appeared first on Express Pharma.

105
105
article thumbnail

10th edition of India Pharma Awards at CPHI celebrates a decade of excellence and innovation in pharma industry

Express Pharma

The selection process was guided by EY and evaluated by a distinguished jury, including a Preliminary Online Jury meet and finalist presentations The India Pharma Week 2023, started from 28 th November till 30 th November on the sidelines of the CPHI show. The awards recognised 44 finalists who compete across 13 categories.

108
108
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Zydus launches IBYRA, the generic version of Olaparib

Express Pharma

Zydus has launched Olaparib, a PARP inhibitor, under the brand name IBYRA in India. Out of 14 lakh newly diagnosed cancer patients in India, nearly 2.75 Zydus is one of the leading players in the oncology segment in India. The drug will target specific genetic mutations prevalent in certain types of cancers.

102
102
article thumbnail

Merck announces Remarkable Merck Young Scientists Awards 2023

Express Pharma

Merck recently announced the winners of Merck Young Scientists Awards, Season-3 to recognise young scientists in India. Held at Bangalore, the annual awards recognise the work of young scientists who are driving positive change in the lives of millions across India through their cutting-edge research in life sciences.

100
100
article thumbnail

SPDS announces DRPI 2023 World-Grant finale

Express Pharma

This event would witness researchers from five regions of the world, namely India, Australia and New Zealand, United States, Japan and South East Asia, and Europe, competing for the global awards under two categories: Early-Stage Researchers (Masters) and Late-Stage Researchers (PhD/Postdoc).

104
104
article thumbnail

Cipla enters deal to distribute Sanofi’s CNS products in India

Pharmaceutical Business Review

This collaboration is expected to leverage Cipla’s extensive distribution network to enhance the reach of Sanofi India’s CNS products. Under the agreement, Cipla will handle the distribution and promotion of six CNS brands owned by Sanofi India, including the anti-epileptic medication Frisium.

article thumbnail

USV and Biogenomics launches Insuquick

Express Pharma

Insuquick is a “Make in India” product and is available in all metros, and tier I/II cities USV has announced a partnership with Biogenomics to launch Insuquick, a biosimilar insulin aspart for people with diabetes In India. Insuquick is a “Make in India” product and is available in all metros, and tier I/II cities.